EEOC v. Dial
This article was originally published in The Rose Sheet
Executive Summary
Sexual harassment trial moves forward after Chicago Court of Appeals rejects Dial's interim appeal on a motion of summary judgement Feb. 12. Lawsuit filed in May 1999 by Equal Employment Opportunity Commission alleges approximately 90 female workers at Dial's Aurora, Ill. soap manufacturing facility were exposed to verbal abuse, pornography and assault. Trial date is not yet set, according to EEOC. Chicago Federal Court denied Dial's motion of summary judgment in August (1"The Rose Sheet" Aug. 27, 2001, In Brief)...
You may also be interested in...
EEOC v. Dial
Sexual harassment case against Dial will proceed after Chicago federal court denies company's motion for summary judgement Aug. 9. Lawsuit filed in May 1999 by Equal Employment Opportunity Commission alleges approximately 90 female workers at Dial's Aurora, Ill. manufacturing facility were exposed to verbal abuse, pornography and assault while the company's response was "malicious, reckless and ineffective." Dial's liability in the case could exceed $25 mil., according to EEOC. Dial maintains, "There is no finding in this decision that Dial violated the law in any manner"
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.